+ Direct Access

Biomarkers: A viable tool in fighting Invasive Candida infections?

EJRC Article Review Invasive Candida infections are leading causes of mortality among critically ill patients. The diagnosis of such diseases is challenging and a delayed start of the appropriate antifungal therapy was associated with a poor prognosis. Accordingly, early empirical antifungal treatment is warranted on the basis of suspected diagnosis. Observational studies have suggested that […]

Read More…


ARE FUNGAL BIOMARKERS USEFUL IN TREATING CANDIDA? Saad Nseir sits down with icTV to discuss the encouraging results from his recently published randomised control trial, which examined the use of a biomarker strategy for early discontinuation of empirical antifungal treatment in critically ill patients. Findings from this trial were presented for the first time publicly during […]

Read More…